Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer

Henrik Nienhüser1, Thomas Schmidt2

  • 1Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany. Henrik.Nienhueser@med.uni-heidelberg.de.

Insights

Anti-angiogenic drugs show promise in treating gastric cancer, expanding from metastatic to perioperative settings. Research highlights key factors and biomarkers for predicting treatment response, addressing current challenges in gastric cancer therapy.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Background:

  • Gastric cancer remains a leading cause of cancer-related deaths globally, with poor prognosis despite diagnostic and therapeutic advancements.
  • Angiogenesis, the formation of new blood vessels, plays a critical role in tumor growth and metastasis.
  • Anti-angiogenic therapies have emerged as a significant treatment modality in oncology.

Purpose of the Study:

  • To provide a comprehensive overview of angiogenesis and angiogenic factors in gastric cancer.
  • To review the current landscape of anti-angiogenic treatment strategies for gastric cancer.
  • To discuss the translational data, clinical trials, and future directions in this field.

Main Methods:

  • Systematic review of in vitro and animal studies on angiogenesis in gastric cancer.
  • Analysis of translational data linking angiogenesis to clinical outcomes.
  • Discussion of published and ongoing clinical trials involving anti-angiogenic drugs in gastric cancer.

Main Results:

  • Key angiogenic factors and their specific roles in gastric cancer progression are identified.
  • Clinical trial data demonstrate the efficacy and evolving application of anti-angiogenic drugs, including in neoadjuvant and perioperative settings.
  • Biomarkers for predicting treatment response are being investigated to personalize therapy.

Conclusions:

  • Anti-angiogenic therapy represents a promising approach for gastric cancer treatment, with expanding applications beyond metastatic disease.
  • Understanding the role of specific angiogenic factors and identifying predictive biomarkers are crucial for optimizing treatment efficacy.
  • Further research and clinical trials are needed to overcome current challenges and improve patient outcomes.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.0K
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
3.4K
Gastric Emptying01:16

Gastric Emptying

Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
4.0K
Gastric Phase of Digestion01:26

Gastric Phase of Digestion

The gastric phase of digestion begins as soon as food enters the stomach. The incoming food bolus triggers neural and hormonal mechanisms, which last approximately 3 to 4 hours. During this phase, the stomach undergoes significant changes to prepare the food for further digestion and absorption.
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
3.6K